Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02958774 · ClinicalTrials.gov registry record · NA

Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation

A NA study of Breast Cancer, sponsored by University of Kansas Medical Center.

Active
Registry status
NA
Development phase
388
Enrollment target
1
Study location

NCT02958774 is a NA study of Breast Cancer that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 388 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02958774, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by University of Kansas Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
388 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to document lymphedema rates in patients requiring regional nodal irradiation (RNI) who receive hypofractionated radiation as compared to conventional radiation.

Conditions Studied

Interventions

  • RADIATION Hypofractionated Radiation Therapy

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 388 participants
Start Date 2017-10-23
Est. Completion 2029-03-01
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT02958774

The ClinicalTrials.gov registry entry for NCT02958774 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 388 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Hypofractionated Radiation Therapy is the first listed.

NCT02958774 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT02958774 about?

NCT02958774 is a clinical study titled "Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation". The primary objective of this study is to document lymphedema rates in patients requiring regional nodal irradiation (RNI) who receive hypofractionated radiation as compared to conventional radiation.

What is the current status of trial NCT02958774?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 388 participants. The study started on 2017-10-23. Estimated completion is 2029-03-01.

What conditions does trial NCT02958774 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02958774?

The interventions under investigation include: Hypofractionated Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT02958774?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02958774 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.